Search results for: Healthcare Systems
Filter search results
Waiting Time Policies in the Health Sector
1 June 2016
This OHE Seminar Briefing summarises a seminar given by Professor Luigi Siciliani on waiting time policies in the health sector from an international perspective, and highlights which policies have worked…
International Comparison of Medicines Usage: Quantitative Analysis from a Swedish Perspective
1 May 2015
The OHE undertook an analysis of the uptake of medicines in 13 high income countries. The UK perspective on this was published in November 2014 by the ABPI. OHE has…
OHE’s 50th Celebration: Publications on Tuberculosis Show Constancy and Change
23 August 2012
…more than 100 booklets on various diseases and conditions as part of a series on “current health problems”. Topics included public health issues and health systems challenges – and also…
Value Based Pricing in Sweden: Lessons for Design?
28 November 2012
…beyond the health sector. This may include the value of caregivers’ time and foregone income, a societal cost often poorly recognised in HTA systems. Second, Sweden does not have a…
New Research by OHE and University of Glasgow on cost of QALYs in Scotland
17 December 2012
…the conclusions drawn from it will be of interest to the whole of the UK, given the similarities in the funding of the health care systems, the services they provide…
Changes in Determining Medicines Pricing in France, Germany and the UK
24 January 2013
…being discussed in pricing and reimbursement/HTA systems in France, Germany and the UK. New requirements for health technology assessment in Europe have important implications for markets and for access to…
New Research: Achieving Efficient Prices for Drugs in a Global Context
7 February 2013
…among other factors. Some features of current regulatory systems are inconsistent with achieving efficiency including, for example, external reference pricing and the inability to price by indication and/or patient subgroup….
OHE This Week: BioWales 2013, UK Medicines Market and EQ-5D in Asia
18 March 2013
19 March: Jon Sussex will be at BioWales 2013 speaking on the health and wider economic benefits of life sciences research. 21 March: Jorge Mestre-Ferrandiz will give his updated annual…
Valuing Orphan Medicines Using Multi-Criteria Decision Analysis
7 May 2013
…that must be made in coverage decisions. In all health care systems, HTA and reimbursement decisions begin with an assessment of value. Many systems take a distinct approach where orphan…